Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

SiriusXM Marine Launches Fish Mapping™ Service – Now Available on Garmin® GXM™ 54 Satellite Weather and Radio Receiver

Published

5 years ago

on

Reading Time: 3 minutes

 

SiriusXM today announced the launch of its new Fish Mapping™ service. This new, comprehensive SiriusXM Marine package – designed to help saltwater anglers locate fish faster, as well as save time and fuel – is now available on the GXM 54 satellite weather and radio receiver from Garmin International, Inc.

SiriusXM Marine’s new Fish Mapping™ service is powered by Maxar Technologies, an innovator in Earth Intelligence and Space Infrastructure. Fish Mapping™ provides regularly updated, science-based graphical information directly on compatible Garmin multi-function displays – even well beyond cellular range.

Maxar has provided enhanced oceanographic datasets and fishing recommendations prepared by the best oceanographers in the industry to commercial fishermen for over 20 years. Now, with the SiriusXM Marine Fish Mapping™ service, anglers can use the same technology to fish more effectively.

Offering premium marine features like recommended areas to find specific game fish, weed lines, sea surface temperatures and front strength, sub surface sea temperatures, and plankton concentration data, Fish Mapping™ is ideal for all salt-water anglers – whether they compete in fishing tournaments, take clients on charter trips, or simply fish for fun.

“We are extremely pleased to team up with Garmin and Maxar for the launch of this game-changing new service,” said Dave Wasby, VP Aviation, Marine, and Music for Business, SiriusXM. “With Garmin’s GXM 54 receiver, anglers can view graphical fishing information directly on the boat’s display. The images are refreshed automatically, without customers needing to initiate a new data request. This easy-to-use service will help anglers identify where game fish are likely to be biting – saving time to reach the best spots for a good day of fishing.”

“Garmin and SiriusXM have worked together for over a decade to provide mariners with best-in-class audio and weather services, and we’re proud to be the first to offer the new Fish Mapping service with our GXM 54 antenna,” said Dan Bartel, Garmin vice president of global consumer sales. “With Fish Mapping content delivered straight to your Garmin chartplotter, you’ll gain added awareness and confidence on the water so you can focus on what’s most important – finding and catching fish.”

“Through our extensive experience in artificial intelligence and machine learning, Maxar gathers content from many sources and combines it with our powerful geospatial analytics system to deliver insights and answers that help customers be more predictive in their decisions,” said Jeff Culwell, Maxar’s Chief Product Officer. “For SiriusXM Marine’s Fish Mapping™ service, we’re providing real-time intelligence that will give serious anglers a leg-up on the competition and help casual anglers enjoy more successful fishing trips.”

SiriusXM Marine’s new Fish Mapping™ service includes:

  • Fishing Recommendations: View locations oceanographers recommend to find specific types of game fish, based on their expert analysis. The locations are overlaid on the angler’s chart and can be viewed in combination with other features.
  • Weed Lines: View concentrations of floating algae/plants, which provide nutrients and cover, creating habitats for bait fish, shrimp, etc., and attract predatory game fish. Weed lines drift and shift over time, so they can be hard to locate. This feature shows anglers where weed lines have been sighted recently, or are most likely to be forming.
  • Sea Surface Height Anomaly: View locations where the sea surface height is different than the surrounding area using actual radar data and models of the sea surface. Shows “upwelling” areas that create favorable conditions including nutrient-rich water that attracts bait fish and game fish – and helps avoid “downwelling” areas that are nutrient poor and don’t support favorable fishing conditions.
  • Sea Surface Temperature Contours: View contour lines where there is sea surface temperature change from cool to warm that attracts bait fish. These contours help locate target species based on their preferred temperature range.
  • Sea Surface Temperature Front Strength: View strength of ocean “fronts”, which are significant temperature changes that create distinct boundaries between bodies of water, concentrating nutrients which attracts bait fish. Strong fronts are good places to find game fish.
  • 30m Subsurface Sea Temperatures: View the water temperature 30 meters below the surface. This feature identifies areas with the preferred temperature range of target game fish in the area below the surface where they are likely to be hunting.
  • Plankton Concentration Contours: View areas of plankton concentrations. Plankton is the primary food source for most bait fish, which attract hungry game fish.
  • Plankton Front Strength: View areas of greatest plankton concentrations with murky, nutrient-rich water favorable for baitfish that are next to areas with relatively little/no plankton with clear, predator-preferred water with better visibility for hunting.

Garmin’s GXM 54 is easy to install and use. With clear line of sight to the sky, its reliable antenna provides the best possible reception — even on the edges of SiriusXM’s coverage area.  

The Fish Mapping™ subscription is $99.99 per month plus applicable fees and taxes. In addition to the eight new fishing features, it includes all of SiriusXM’s weather information from the SiriusXM Marine Offshore Weather package. The subscription can be suspended at no charge for up to six months each year.

SiriusXM and Garmin have teamed up to offer $250 in combined rebates on the GXM 54 receiver. For details visit: https://garmin.blogs.com/promotions/2019/08/2019gxm54rebate.html.

SiriusXM’s services available on Garmin also include SiriusXM Marine Offshore Weather, SiriusXM’s top-level weather package, as well as SiriusXM’s audio entertainment programming.

Related Topics:
Continue Reading

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

2 weeks ago

on

April 5, 2024

By

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

2 weeks ago

on

April 5, 2024

By

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

2 weeks ago

on

April 5, 2024

By

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading
Advertisement
Advertisement

Latest news

Trending